Literature DB >> 6177822

Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.

E R Podack, J Tschoop, H J Müller-Eberhard.   

Abstract

Evidence has been presented suggesting that during assembly of the membrane attack complex (MAC) of complement, the C5b-8 complex induces polymerization of C9. The C9 polymer was detected by sodium dodecyl sulfate (SDS) gel electrophoresis of MAC isolated from complement-lysed erythrocytes. It resembled the previously described polymerized C9 (poly C9) produced from isolated monomeric C9 by prolonged incubation at 37 degrees C in that it was resistant to dissociation by SDS and reducing agents and had an apparent molecular weight of approximately 1.1 million. The presence of poly C9 in the MAC was further supported by the expression of identical neoantigens by the MAC and poly C9 and by the high C9 content of the MAC relative to its other constituents. Isolated C8 in solution was found to have a single C9-binding site. In mixture, the two proteins formed a reversible equimolar complex that had a sedimentation coefficient of 10.5S. In contrast, a single, cell-bound C5b-8 complex was found to bind up to 12-15 C9 molecules and clusters of C5b- 8 bound 6-8 C9 molecules per C8 molecule. In either case, typical ultrastructural membrane lesions were observed, suggesting that the membrane lesion is identical with the tubular poly C9 consisting of 12-16 C9 molecules, and that the MAC can have either the composition (C5b-8)polyC9 or (CSb-8)(2)polyC9. When C9 input was restricted so that the molar C9/C8 ratio was less than or equal to 3, C9-induced aggregates of C5b-8 were observed but virtually no circular membrane lesions were found. We suggest, therefore, that C9, at low dosage, causes cross-linking of multiple C5b-8 complexes within the target membrane and that, at high dosage, C9 is polymerized by C5b-8 to form a transmembrane channel within the MAC assembly. It is primarily the C9 polymer that evokes the ultrastructural image of the MAC or of membrane lesions caused by complement.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177822      PMCID: PMC2186720          DOI: 10.1084/jem.156.1.268

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system.

Authors:  R L Stolfi
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

2.  Mechanism of cytolysis by complement.

Authors:  M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

3.  The ninth component of human complement: isolation, description and mode of action.

Authors:  U Hadding; H J Müller-Eberhard
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

4.  Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8.

Authors:  W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

5.  Studies of guinea pig complement component C9: reaction kinetics and evidence that lysis of EAC1-8 results from a single membrane lesion caused by one molecule of C9.

Authors:  F A Rommel; M M Mayer
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Isolation of the terminal complement complex from target sheep erythrocyte membranes.

Authors:  S Bhakdi; P Ey; B Bhakdi-Lehnen
Journal:  Biochim Biophys Acta       Date:  1976-02-06

8.  Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

Authors:  B H Petersen; J A Graham; G F Brooks
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

9.  Molecular analysis of the membrane attack mechanism of complement.

Authors:  W P Kolb; J A Haxby; C M Arroyave; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

10.  The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex.

Authors:  W P Kolb; H J Muller-Eberhard
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more
  47 in total

1.  An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.

Authors:  Ann Orren; Ann M O'Hara; B Paul Morgan; Anthony P Moran; Reinhard Würzner
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).

Authors:  Alexander E Aleshin; Ingrid U Schraufstatter; Boguslaw Stec; Laurie A Bankston; Robert C Liddington; Richard G DiScipio
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

3.  Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.

Authors:  G Triolo; E Giardina; D Casiglia; G Scarantino; G D Bompiani
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

4.  Pore-forming peptide of pathogenic Entamoeba histolytica.

Authors:  M Leippe; S Ebel; O L Schoenberger; R D Horstmann; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.

Authors:  J Tschopp; T E Mollnes
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Physicochemical characterization of human S-protein and its function in the blood coagulation system.

Authors:  K T Preissner; R Wassmuth; G Müller-Berghaus
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

8.  Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.

Authors:  C L Koski; M E Sanders; P T Swoveland; T J Lawley; M L Shin; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

9.  The kinetics and distribution of C9 and SC5b-9 in vivo: effects of complement activation.

Authors:  J D Greenstein; P W Peake; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

10.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.